Click for best price
NonSteroidal AntiInflammatory Drugs NSAIDs Market Size, Share 2023
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
This report aims to provide a comprehensive presentation of the global market for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). This report contains market size and forecasts of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in global, including the following market information:
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Aspirin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) include Roche (Genentech), Amgen, B-MS, Merck, Pfizer, Novartis, Eli Lilly and Company, Johnson & Johnson and GSK, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Percentages, by Type, 2022 (%)
Aspirin
Ibuprofen
Naproxen
Celecoxib
Others
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Percentages, by Application, 2022 (%)
Drug Store
Hospital Pharmacies
Online
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche (Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), market overview.
Chapter 2: Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market size in revenue.
Chapter 3: Detailed analysis of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Overall Market Size
2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size: 2022 VS 2032
2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players in Global Market
3.2 Top Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies Ranked by Revenue
3.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Companies
3.4 Top 3 and Top 5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players in Global Market
3.6.1 List of Global Tier 1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies
3.6.2 List of Global Tier 2 and Tier 3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Markets, 2022 & 2032
4.1.2 Aspirin
4.1.3 Ibuprofen
4.1.4 Naproxen
4.1.5 Celecoxib
4.1.6 Others
4.2 By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue & Forecasts
4.2.1 By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2023
4.2.2 By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2024-2032
4.2.3 By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2022 & 2032
5.1.2 Drug Store
5.1.3 Hospital Pharmacies
5.1.4 Online
5.2 By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue & Forecasts
5.2.1 By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2023
5.2.2 By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2024-2032
5.2.3 By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2022 & 2032
6.2 By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue & Forecasts
6.2.1 By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2023
6.2.2 By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2024-2032
6.2.3 By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2032
6.3.2 US Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.3.3 Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.3.4 Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2032
6.4.2 Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.4.3 France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.4.4 U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.4.5 Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.4.6 Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.4.7 Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.4.8 Benelux Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2032
6.5.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.5.3 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.5.4 South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.5.5 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.5.6 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2032
6.6.2 Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.6.3 Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2032
6.7.2 Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.7.3 Israel Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.7.4 Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
6.7.5 UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, 2018-2032
7 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies Profiles
7.1 Roche (Genentech)
7.1.1 Roche (Genentech) Company Summary
7.1.2 Roche (Genentech) Business Overview
7.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.1.4 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.1.5 Roche (Genentech) Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.2.4 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 B-MS
7.3.1 B-MS Company Summary
7.3.2 B-MS Business Overview
7.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.3.4 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.3.5 B-MS Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.4.4 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.5.4 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.6.4 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Company Summary
7.7.2 Eli Lilly and Company Business Overview
7.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.7.4 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.7.5 Eli Lilly and Company Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.8.4 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 GSK
7.9.1 GSK Company Summary
7.9.2 GSK Business Overview
7.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.9.4 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.9.5 GSK Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.10.4 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Company Summary
7.11.2 Boehringer Ingelheim Business Overview
7.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.11.4 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.11.5 Boehringer Ingelheim Key News & Latest Developments
7.12 Zhejiang Jiuzhou Pharmaceutical
7.12.1 Zhejiang Jiuzhou Pharmaceutical Company Summary
7.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
7.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Major Product Offerings
7.12.4 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global Market (2018-2023)
7.12.5 Zhejiang Jiuzhou Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Opportunities & Trends in Global Market
Table 2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers in Global Market
Table 3. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints in Global Market
Table 4. Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Global Market
Table 5. Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Companies, 2018-2023
Table 8. Global Companies Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Type
Table 9. List of Global Tier 1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2024-2032
Table 30. Roche (Genentech) Company Summary
Table 31. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 32. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 33. Roche (Genentech) Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 36. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. B-MS Company Summary
Table 39. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 40. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 41. B-MS Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 44. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 48. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Novartis Company Summary
Table 51. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 52. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 53. Novartis Key News & Latest Developments
Table 54. Eli Lilly and Company Company Summary
Table 55. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 56. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 57. Eli Lilly and Company Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 60. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. GSK Company Summary
Table 63. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 64. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 65. GSK Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 68. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 69. Sanofi Key News & Latest Developments
Table 70. Boehringer Ingelheim Company Summary
Table 71. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 72. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 73. Boehringer Ingelheim Key News & Latest Developments
Table 74. Zhejiang Jiuzhou Pharmaceutical Company Summary
Table 75. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product Offerings
Table 76. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (US$, Mn) & (2018-2023)
Table 77. Zhejiang Jiuzhou Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type in 2022
Figure 2. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application in 2022
Figure 3. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2022
Figure 8. By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
Figure 9. By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
Figure 10. By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
Figure 12. By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
Figure 14. By Region - Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
Figure 15. By Country - North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
Figure 16. US Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
Figure 20. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 21. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
Figure 28. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 32. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
Figure 34. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share, 2018-2032
Figure 37. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue, (US$, Mn), 2018-2032
Figure 41. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
